Although statistical significance was not reached in the other staging systems, the mean changes in DLCO showed a trend toward a significant difference in patients with greater HRCT involvement in the placebo group.
← all excerpts
Predictors of lung function decline in scleroderma-related interstitial lung disease based on high-resolution computed tomography: implications for cohort enrichment in systemic sclerosis-associated interstitial lung disease trials.
1
—
—